City of Hope’s Mustafa Raoof: Medicare Advantage cancer patients more likely to die within 30 days after complex surgery

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Medicare Advantage, the private insurance alternative to traditional Medicare, is popular for several reasons: lower premiums, dental and vision coverage, and a cap on out-of-pocket costs.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login